EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin-17A directly triggers Epstein-Barr virus lytic reactivation in latency I human B-cell models

Janardhan Avilala, Hirotomo Dochi, Ramsy Abdelghani, David Becnel, Grace Maresh, Xin Zhang, Li Li, Mark Sides, Gilbert Morris, Hong Liu, Zhen Lin iD

Journal of Virology · 2026

DOI: 10.1128/jvi.00813-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Janardhan Avilala und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Interleukin-17, B-Lymphocytes, Virus Activation. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) is a ubiquitous human gammaherpesvirus implicated in inflammatory, malignant, and autoimmune diseases. Although EBV toggles between latent and lytic states, the host cues controlling this switch remain incompletely defined. Interleukin-17A (IL-17A), a signature Th17 cytokine, is enriched in EBV-associated inflammatory settings, and EBV products can augment IL-17A responses. Whether IL-17A directly regulates the EBV life cycle has remained unknown. Here, we show that IL-17A alone is sufficient to induce EBV lytic reactivation in latency I human B-cell models. IL-17A increased BZLF1/Zta, activated the BZLF1 promoter (Zp), induced early and late lytic genes and proteins, and promoted DNase-resistant EBV DNA release and infectious virion production. Mechanistically, IL-17A activated NF-κB and ERK/p38 MAPK signaling, including phosphorylation of p65, ERK1/2, and p38. IL-17RA blockade reduced IL-17A-induced signaling and lytic reactivation, and pharmacologic inhibition of NF-κB or p38 MAPK signaling attenuated EBV reactivation. Among IL-17 family members tested, only IL-17A induced reactivation. RNA-seq provided a transcriptome-wide view of the viral and cellular response to IL-17A, revealing broad EBV lytic transcription and inflammatory, NF-κB-associated, and B-cell activation programs. IL-17A responsiveness was latency- and cell-state restricted: latency I B-cell models responded, whereas latency II/III, lymphoblastoid, and EBV-positive epithelial models did not. Subinducing IL-17A (1 ng/mL) was insufficient alone but enhanced B-cell receptor-mediated reactivation, suggesting threshold-lowering activity in inflammatory B-cell niches. Together, these findings identify IL-17A as a receptor-linked inflammatory cue for EBV lytic entry and provide the first demonstration that IL-17A alone directly triggers EBV lytic reactivation in human cells. IMPORTANCE Epstein-Barr virus (EBV) persists for life by maintaining latency with lytic reactivation, yet the inflammatory cues that initiate this switch remain poorly defined. Here, we identify interleukin-17A (IL-17A), a Th17 cytokine, as a direct trigger of EBV lytic reactivation in latency I human B-cell models. IL-17A activates IL-17RA-linked NF-κB/MAPK signaling, induces BZLF1/Zta and downstream lytic genes, and promotes DNase-resistant EBV DNA release and infectious virion production. IL-17RA blockade and inhibition of NF-κB/p38 MAPK signaling reduce reactivation, supporting a receptor-linked mechanism rather than nonspecific stress. Subinducing IL-17A (1 ng/mL) was insufficient to reactivate EBV alone but enhanced B-cell receptor-mediated reactivation, suggesting threshold-lowering activity in inflammatory B-cell niches. The response is restricted by latency and cell state, indicating that IL-17A signaling must be coupled to a permissive EBV lytic switch. These findings connect Th17-skewed inflammation to EBV reactivation burden and suggest that IL-17A/IL-17R signaling may influence EBV pathogenesis in inflammatory and malignant settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanInterleukin-17B-LymphocytesVirus ActivationVirus LatencyEpstein-Barr Virus InfectionsHumansTrans-ActivatorsNF-kappa BGene Expression Regulation, ViralSignal TransductionPromoter Regions, Genetic

Stichwörter der Autor:innen

EBVEpstein-Barr virusIL-17AMAPKNF-κBRNA-seqcytokine signalinginterleukin-17Alytic reactivation

Substanzen

Interleukin-17Trans-ActivatorsNF-kappa BBZLF1 protein, Herpesvirus 4, HumanIL17A protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Section of Pulmonary and Critical Care Medicine and Interventional Pulmonology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Translational Cancer Research Laboratory, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
  • Section of Hematology and Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

ORCID-Profile: Zhen Lin

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Avilala, J., Dochi, H., Abdelghani, R., Becnel, D., Maresh, G., Zhang, X., Li, L., Sides, M., Morris, G., Liu, H., & Lin, Z. (2026). Interleukin-17A directly triggers Epstein-Barr virus lytic reactivation in latency I human B-cell models. Journal of Virology. https://doi.org/10.1128/jvi.00813-26

Vancouver

Avilala J, Dochi H, Abdelghani R, Becnel D, Maresh G, Zhang X, et al. Interleukin-17A directly triggers Epstein-Barr virus lytic reactivation in latency I human B-cell models. Journal of Virology. 2026. doi:10.1128/jvi.00813-26

BibTeX
@article{Avilala2026,
  author = {Avilala, Janardhan and Dochi, Hirotomo and Abdelghani, Ramsy and Becnel, David and Maresh, Grace and Zhang, Xin and Li, Li and Sides, Mark and Morris, Gilbert and Liu, Hong and Lin, Zhen},
  title = {Interleukin-17A directly triggers Epstein-Barr virus lytic reactivation in latency I human B-cell models},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.00813-26}
}
Kostenlos starten →